Ana Castedo, who brings a strong focus on patent litigation, will help build the firm’s IP litigation offering in Madrid
With rumours that a third IP judge could yet join the England and Wales High Court, we run through some potential names while practitioners outline the importance of a well-stocked bench
The firm hopes its recent Düsseldorf expansion and UK partner hire will strengthen its offering as it looks to an integrated model to boost UPC capabilities
Two judicial appointments confirmed in Paris and Mannheim, while cross-border injunctions and high-profile procedural rulings keep major patent practices occupied
Recent lateral moves raise a bigger question for full-service firms – can patent litigation remain a strategic priority when competing practices generate larger profits?
Christopher Stothers' arrival strengthens the firm's life sciences, technology and UPC offering as competition for top European litigators intensifies
Increased focus on adding patent litigation depth to the firm’s Dallas office was behind the boutique’s most recent hires
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
The firm says new additions position Brown Rudnick as a market leader in tech, life sciences, and global litigation
Amongst a sea of mergers, Lathrop GPM and HG Law have set out plans to combine, positioning themselves to compete with both IP boutiques and full-service firms
Labelled the ‘largest law firm merger in history’, the new outfit could also spell an opportunity for US clients to capitalise on Hogan Lovells' UPC expertise
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property explains how the CNIPA decision clarifies sufficient disclosure and inventive step for pharmaceutical use patents
-
Sponsored by Licks AttorneysEduardo Hallak, Juliana Neves, and Juliana Libman of Licks Attorneys examine how Brazil's new skinny-label regime may affect patent infringement claims, particularly those involving contributory infringement, when patented medical uses continue despite regulatory carve-outs
-
Sponsored by IPSILONJoran Michiels of IPSILON Belgium examines how recent EPO and UPC decisions may support inventive-step arguments for CARs, ADCs, bispecific antibodies, and other next-generation therapeutics
Todd Hopfinger, director in Sterne Kessler’s electronics practice group, says IP owners are contemplating how patent rights will be enforced as commercial activity expands beyond Earth
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
After more than three decades at Wilson Sonsini, Ian Edvalson explains why he moved to expand his life sciences transactional practice
Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future
Interviews; Exclusives
Interviews; Exclusives
Firm says its work with a nonprofit client could signal a sea change in how - and when - law firms enter the drug development process
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Natasha Daughtrey shares how firms can help their women litigators take the lead on trials, and why she is seeing a convergence of tech and life sciences disputes
Mathew Lucas has joined Pearce IP after spending more than 25 years at Qantm IP-owned firm Davies Collison Cave
Managing partner Mark O’Donnell explains why people are at the centre of the Australian outfit’s investment focus and how being independent benefits the firm
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
-
Weekly take: Why Hikma decision shows external factors could have increased influence
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market -
Weekly take: Why ‘impossible to ignore’ IP became my 'Jedi path'
Shaina Haria, a final-seat trainee at an international law firm’s UK office, shares how she fell in love with IP and why the area of law has changed the way she views the world -
Weekly take: Why the EU must press ahead with unitary SPCs
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer -
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue
The shortlist for our annual Americas Awards will be published next month, with potential winners in more than 90 categories set to be revealed
The LMG Life Sciences Awards announces the 2025 winners for the 13th annual awards!
Practitioners and law firms should keep their eyes peeled as the shortlist for our annual Awards is set to be released